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Introduction {#sec1}
============

PBAF is a SWI/SNF chromatin remodeling complex found in mammalian cells. BAF180 is one of three subunits that distinguish PBAF (or SWI/SNF-B) from the other SWI/SNF complex, termed BAF (or SWI/SNF-A). Recent exome sequencing studies led to the unexpected finding that SWI/SNF subunits are mutated at a high frequency in many different cancer types, and in particular, mutations in *PBRM1*, which encodes BAF180, were frequently identified, including in over 40% of renal cell carcinoma samples ([@bib21], [@bib25], [@bib28]), indicating that BAF180 plays a critical role in preventing tumorigenesis. Even though BAF180 was identified as a regulator of p53-dependent transcriptional activity ([@bib6], [@bib28]), it is unclear whether this is the mechanism by which it functions as a tumor-suppressor gene.

BAF180 is a large protein with multiple domains, including six bromodomains (BDs) and two bromo-adjacent homology (BAH) domains. In yeast, these domains are encoded by three separate subunits, Rsc1, Rsc2, and Rsc4, which are part of the RSC chromatin remodeling complex. In addition to regulating gene transcription, RSC is important for sister chromatid cohesion ([@bib2], [@bib14]). Notably, recent reports demonstrated that defective cohesion results in chromosomal instability (CIN) and aneuploidy, and leads to tumorigenesis in mammalian cells ([@bib8], [@bib11], [@bib20], [@bib22], [@bib23]). Moreover, aneuploidy itself can drive further genome instability and can also, in certain contexts, contribute to tumorigenesis (for review, see [@bib12]). These observations raise the possibility that a major mechanism by which BAF180 functions as a tumor suppressor is by promoting sister chromatid cohesion.

Results {#sec2}
=======

BAF180 Contributes to Sister Chromatid Cohesion Specifically at Centromeres in Mammalian Cells {#sec2.1}
----------------------------------------------------------------------------------------------

To test whether BAF180 is important for sister chromatid cohesion, we first prepared chromosome spreads from wild-type (WT) or BAF180 knockout mouse embryonic stem cells (mESCs) ([@bib27]). When we scored for cohesion at the centromere, we found that the BAF180^−/−^ cells showed a significant increase in the proportion of cells that displayed aberrant cohesion compared with the WT control cells ([Figure 1](#fig1){ref-type="fig"}A).

In higher eukaryotes, the cohesin complex can contain either SA1 (STAG1) or SA2 (STAG2), and recently it was found that SA1 is required for cohesion between sister telomeres, whereas SA2 is required for centromeric cohesion ([@bib7], [@bib20]). We therefore scored cohesion at the chromosome arms to determine whether there was also a defect, and found no statistically significant difference between the BAF180^+/+^ and BAF180^−/−^ mESCs ([Figure 1](#fig1){ref-type="fig"}B), suggesting that BAF180 specifically promotes cohesion at the centromeres.

To further examine the cohesion defect, we depleted BAF180 using small interfering RNA (siRNA) in human fibroblast cells (1BR hTERT; [Figure 1](#fig1){ref-type="fig"}C) and performed fluorescence in situ hybridization (FISH; [Figure S1](#app2){ref-type="sec"}). We first measured the distance between sister chromatids in mitotic cells using a probe specific to centromere 10. Compared with cells transfected with a nontargeting control construct, we found a shift in the distribution of distances between sister chromatids at the centromere ([Figures 1](#fig1){ref-type="fig"}D, top panel, and [S1](#app2){ref-type="sec"}), consistent with the analysis of cohesion in mESCs.

The data we obtained from mouse cells indicated that the defect in cohesion is specific to the centromere; therefore, we tested whether BAF180 is also important for mediating cohesion between telomeres. Using a probe against the subtelomeric region of chromosome 16, we measured the distribution of distances between sister chromatids in siBAF180 and siControl cells as above. In contrast to our results with the centromeric probe, we found no significant difference in the BAF180-depleted cells compared with the control cells ([Figures 1](#fig1){ref-type="fig"}D, middle panel, and [S1](#app2){ref-type="sec"}). Finally, we used a probe against the chromosome arm (20p12), and found no substantial difference between siBAF180 and control cells ([Figures 1](#fig1){ref-type="fig"}D, bottom panel, and [S1](#app2){ref-type="sec"}). These data are similar to results obtained with SA2-depleted cells ([@bib7]), so we performed knockdown of SA2 and repeated the analysis of centromeres by FISH in order to compare the defect with that of BAF180. We found that the shift in distribution of distances between centromeres was slightly greater than that of BAF180 ([Figure S1](#app2){ref-type="sec"}), suggesting that loss of BAF180 may not be as deleterious as loss of SA2.

To consolidate these data, and for use in future experiments, we also created a BAF180 small hairpin RNA (shRNA) stable cell line (and shControl cell line) in U2OS cells ([Figure 1](#fig1){ref-type="fig"}E). We analyzed these cells by FISH as described above using the centromere-specific probe, and found that, consistent with the data from mESCs and human fibroblast cells, U2OS cells depleted of BAF180 have a defect in cohesion at the centromere ([Figure 1](#fig1){ref-type="fig"}F). Together, these data suggest that BAF180 plays a conserved role in mediating centromeric sister chromatid cohesion in mammalian cells.

BAF180 Is Not Required for Transcription of Cohesin Genes and Has Tissue-Specific Roles in Regulating p53-Dependent p21 Transcription {#sec2.2}
-------------------------------------------------------------------------------------------------------------------------------------

One possible mechanism by which BAF180 mediates sister chromatid cohesion in cells is transcriptional regulation of cohesin genes. In argument against this, a microarray analysis of BAF180-depleted renal cell carcinomas did not show significant misregulation of cohesin genes ([@bib25]). Moreover, we saw no gross differences in the protein levels of core cohesin subunits when whole-cell extracts from BAF180^+/+^ and BAF180^−/−^ cells were analyzed by western blotting ([Figure 2](#fig2){ref-type="fig"}A).

Nevertheless, to look at this directly in the human cell lines used in these assays, we examined the mRNA levels of the core cohesin genes *SMC1A*, *SMC3*, *SA1* (*STAG1*), *SA2* (*STAG2*), and *RAD21* in siBAF180-treated 1BR hTERT cells and the stable shBAF180 U2OS cells, and compared them with controls using quantitative RT-PCR (qRT-PCR). BAF180 depletion did not result in significantly decreased levels of any of these transcripts ([Figures 2](#fig2){ref-type="fig"}B and 2C). In fact, in the shBAF180 U2OS cells, the *RAD21* transcript, and to a lesser extent the *SMC3* and *SA1* transcripts, appeared to be upregulated. Together, these data suggest that the defect in cohesion is unlikely to be due to indirect transcriptional effects.

BAF180 has been implicated in regulating transcription of the p53-dependent p21 gene ([@bib6], [@bib28]), and this is certainly a mechanism by which loss of BAF180 may promote tumorigenesis. We set out to investigate the transcriptional status of p21 in our BAF180-depleted cell lines and found that, consistent with previous reports, the basal levels of p21 transcription were defective in a human fibroblast cell line ([Figure 2](#fig2){ref-type="fig"}D). Moreover, we examined induced p21 transcription by treating cells with the MDM2 inhibitor nutlin, and found that these transcripts were also downregulated when BAF180 was depleted in the 1BR hTERT cells ([Figure S2](#app2){ref-type="sec"}).

In contrast, however, both basal and induced p21 transcripts were upregulated in the U2OS shBAF180 cells relative to the shControl cells ([Figures 2](#fig2){ref-type="fig"}D and [S2](#app2){ref-type="sec"}), suggesting that p53-dependent transcriptional activation of p21 is BAF180 independent in these cells. This finding fortuitously allowed us to examine the effects of BAF180-dependent effects on cohesion in a cell line where p21 transcription is not reduced.

Cancer-Associated Mutations of BAF180 Impair Cohesion in Mammalian Cells and Cohesin-Dependent Functions in Budding Yeast {#sec2.3}
-------------------------------------------------------------------------------------------------------------------------

A number of missense mutations were identified in the gene encoding BAF180 (*PBRM1*) in cancer cells ([@bib25]), some of which are predicted to have relatively little effect on protein folding and stability ([@bib5]). We considered the possibility that these mutations might provide some insight into the mechanism(s) by which BAF180 suppresses tumorigenesis. We began by looking at the effects of these cancer mutations in the yeast homolog of BAF180.

We selected three mutations of BAF180 identified in cancer cells: T232P, M523I, and H1204P. The first two reside in BD2 and BD4 of BAF180, and the last mutation is found within the second BAH domain of BAF180. When aligned with Rsc1 and Rsc2, all three residues are conserved within Rsc2 ([Figures 3](#fig3){ref-type="fig"}A, [S3](#app2){ref-type="sec"}A, and S3B; corresponding to T67 in BD1, M280 in BD2, and H458P in the BAH domain, respectively). Although two of the residues are also conserved within Rsc1 ([Figures S3](#app2){ref-type="sec"}A and S3B), Rsc2 has a greater effect on DNA damage responses and cohesion ([@bib2], [@bib9]), so we introduced the mutations into Rsc2.

We first transformed WT and mutant Rsc2 expression constructs into *rsc2* null yeast and then performed western blot analyses of whole-cell extracts to determine whether they had any effect on protein stability. We detected a very low level of Rsc2-H458P mutant protein compared with the WT control, suggesting that this mutation severely impairs protein stability. The Rsc2-T67P mutant protein was detected at intermediate levels, consistent with a slight destabilizing effect, and the Rsc2-M280I was similar to WT ([Figure 3](#fig3){ref-type="fig"}B).

Cells lacking *RSC2* have a growth defect and are temperature sensitive. They are also hypersensitive to DMSO, which likely reflects transcriptional misregulation of genes involved in cell wall biosynthesis ([@bib1]). We found the Rsc2-H458P mutant strain showed phenotypes similar to those of the null strain ([Figures 3](#fig3){ref-type="fig"}C and [S3](#app2){ref-type="sec"}), consistent with the greatly reduced protein levels. In contrast, both of the other mutant proteins were able to rescue the temperature-sensitivity (ts) and DMSO-hypersensitivity phenotypes of the *rsc2* null strain to apparently WT levels ([Figures 3](#fig3){ref-type="fig"}C and [S3](#app2){ref-type="sec"}), as well as to restore the WT levels of the *HXT7* transcript, which is Rsc2 dependent ([Figure S3](#app2){ref-type="sec"}). These results indicate that the Rsc2-T67P and Rsc2-M280I mutant proteins are still at least partly functional in vivo. In contrast, we found that all of the cancer-mutant-bearing strains showed statistically significant differences in survival relative to WT following DNA damage, and none of the cancer-mutant constructs were able to fully complement the growth defect ([Figure S3](#app2){ref-type="sec"}).

The yeast phenotypes described above could potentially reflect a loss of cohesion-dependent activities in the cancer-mutant-containing strains. We therefore tested the mutant Rsc2 proteins using a recombination assay in which a reporter construct was integrated into the rDNA repeats. Strains with defective cohesion showed elevated rates of marker loss compared with WT, indicative of increased unequal sister chromatid exchange events ([@bib13]). As expected, the *rsc2* null cells showed a 3-fold increase in marker loss compared with the WT control ([Figure 3](#fig3){ref-type="fig"}D). Notably, we found that none of the cancer mutations were able to fully complement this activity ([Figure 3](#fig3){ref-type="fig"}D). These data are consistent with the idea that some cancer-associated mutations do not compromise all functions of Rsc2, but do compromise the cohesion-related functions of *RSC2* and result in genome instability.

We next created siRNA-resistant GFP-tagged WT and mutant expression constructs of BAF180. We focused on the two mutants that were expressed at reasonable levels in yeast: Rsc2-T67P and M280I. These correspond to BAF180 T232 and M538 in our construct (isoform 8; [Figure S3](#app2){ref-type="sec"}). We then transfected these constructs into BAF180-depleted cells alongside WT and empty vector, synchronized them in G2, and analyzed them by immunofluorescence (IF)-FISH to examine the distance between sister chromatids in the transfected cells ([Figures 3](#fig3){ref-type="fig"}E, 3F, and [S4](#app2){ref-type="sec"}). We found that expression of the mutants was comparable to that of the WT construct ([Figures 3](#fig3){ref-type="fig"}E and [S4](#app2){ref-type="sec"}), but although the WT construct was able to restore cohesion, neither of the cancer-associated mutant constructs could ([Figures 3](#fig3){ref-type="fig"}G and 3H), suggesting that tumor cells bearing these mutations have compromised centromeric cohesion.

Loss of BAF180 Leads to Dynamic CIN {#sec2.4}
-----------------------------------

Defective cohesion leads to both structural and numerical CIN, due in part to problems with chromosome segregation leading to aneuploidy, and defective recombination-based repair leading to structural chromosome aberrations ([@bib29]). Cells lacking SA2, which have centromeric cohesion defects similar to BAF180-dependent effects, are aneuploid and show evidence of both structural and numerical CIN ([@bib22]). However, the effect of BAF180 depletion on sister chromatid cohesion is not as pronounced as that reported for SA2-depleted cells ([Figure S2](#app2){ref-type="sec"}; [@bib7]), raising the possibility that this defect is not sufficient to disrupt chromosomal stability and therefore may not impact tumorigenesis. We therefore investigated whether loss of BAF180 leads to CIN.

We first determined whether BAF180 influences aneuploidy by analyzing chromosome spreads prepared from BAF180^−/−^ mESCs, and found that they had an increased average number of chromosomes per cell when compared with WT ([Figure 4](#fig4){ref-type="fig"}A). Next, we investigated other readouts of CIN. Micronuclei can arise as a consequence of chromosome missegregation and are commonly seen in cells with defective cohesion ([@bib3], [@bib17]). We observed an increase in the number of micronuclei present in the BAF180^−/−^ mESCs compared with WT ([Figure 4](#fig4){ref-type="fig"}B, top panel). A similar increase was apparent when we examined the human cell lines depleted of BAF180 (siBAF180 1BR hTERT cells and shBAF180 U2OS) when compared with their controls ([Figure 4](#fig4){ref-type="fig"}B, middle and lower panels). Notably, the result obtained in the siBAF180-treated cells suggests that the effect of BAF180 loss on genome stability is rapid and does not require extensive cell passaging. Further, imaging of BAF180^−/−^ mESCs showed the presence of increased numbers of lagging chromosomes and anaphase bridges compared with WT control cells ([Figure 4](#fig4){ref-type="fig"}C).

In addition to promoting faithful chromosome segregation, cohesion is important for mediating recombination in response to DNA damage, and loss of cohesion leads to structural CIN ([@bib29]). Consequently, mammalian cells with defects in cohesion are hypersensitive to a number of DNA-damaging agents, including the crosslinking agent mitomycin C (MMC) ([@bib24], [@bib26]). We therefore tested whether loss of BAF180 would sensitize cells to MMC. We found that both BAF180^−/−^ mESCs and BAF180-depleted 1BR-hTERT human cells were more sensitive to MMC than the respective WT cells ([Figure 5](#fig5){ref-type="fig"}A). These data suggest that loss of cohesion in the absence of BAF180 leads to a deficiency in recombination-based repair of DNA damage, leading to decreased viability after MMC exposure.

This defect would be expected to further exacerbate CIN in the absence of BAF180 under these conditions. Consistent with this idea, we found that the BAF180^−/−^ mESCs had a clear increase in structural aberrations and greater incidence of micronuclei than the WT controls following exposure to MMC ([Figures 5](#fig5){ref-type="fig"}B and 5C; [Table 1](#tbl1){ref-type="table"}). Strikingly, we also found that MMC treatment led to a profound effect on aneuploidy in the BAF180^−/−^ cells ([Figure 5](#fig5){ref-type="fig"}D), providing direct evidence of dynamic CIN in these cells. We also found that the shBAF180 U2OS cells, where p21 transcripts are not decreased relative to the shControl cells, also showed evidence of MMC-induced genome instability ([Figure S5](#app2){ref-type="sec"}). Collectively, these data demonstrate that BAF180 plays a key role in preventing CIN.

Discussion {#sec3}
==========

We found that BAF180 is important for the establishment or maintenance of cohesion on chromatin at centromeres. Interestingly, BAF180 is enriched at kinetochores of chromosomes during mitosis ([@bib30]), and there is evidence from budding yeast that kinetochores promote cohesin loading by Scc2-Scc4 ([@bib18]), raising the possibility that PBAF works with kinetochores in some way to promote this function.

We found that cancer-associated mutations in BAF180 are compromised for cohesion and cohesion-dependent functions in both yeast and mammalian cells, demonstrating profound conservation of function. These findings, together with the CIN that we find in the absence of BAF180, support the notion that the ability of BAF180 to promote cohesion is important for preventing tumorigenesis. Notably, these data are not incompatible with the idea that BAF180 also prevents tumorigenesis via its role in regulating transcription; rather, they uncover an additional mechanism. In fact, the ability of BAF180 (and PBAF) to function in multiple pathways to prevent tumorigenesis may make it particularly critical as a tumor-suppressor gene, and may explain the frequency with which subunits of the complex are found mutated in cancer samples.

We find evidence of both structural and numerical CIN. Loss of centromeric cohesion is likely to disrupt accurate chromosome segregation and would therefore lead to numerical CIN. Although it is less obvious how a defect in cohesion at the centromere would lead to structural CIN, evidence of both structural and numerical CIN has been reported for cells lacking other members of the centromere-specific cohesion pathway, i.e., SA2 and PDS5B ([@bib4], [@bib8], [@bib16], [@bib22]). Cohesin is recruited to sites of DNA damage in order to promote recombination-based repair, and in yeast this is dependent on RSC ([@bib19]). Interestingly, a recent report suggests that SA2, but not SA1, is recruited to sites of DNA damage ([@bib16]). Together, these findings raise the intriguing possibility that the establishment of cohesion in response to DNA damage is mediated specifically by the centromere-specific cohesion pathway.

These results demonstrate a role for BAF180 in promoting genome stability that is distinct from its well-characterized role in transcriptional regulation. The discovery that BAF180 contributes to cohesion suggests potential directions for therapeutic interventions for BAF180-deficient tumors.

Experimental Procedures {#sec4}
=======================

Cell Culture Conditions, Strains, Plasmids, and Antibodies {#sec4.1}
----------------------------------------------------------

For details regarding the cell culture conditions, strains, plasmids, and antibodies used in this work, see [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Metaphase Spreads {#sec4.2}
-----------------

To arrest cells in metaphase, the cells were treated with 0.1 μg/ml colcemid for 3 hr, trypsinized, swollen in 75 mM KCl for 20 min at room temperature, and fixed in Carnoy's fixative (methanol/acetic acid 3:1). Cells were spotted onto a slide floating in a 37°C waterbath and dried overnight at room temperature. DNA staining was performed using ProLong Gold Antifade Reagent (Life Technologies) with DAPI. For the mESC cohesion assays, 200 spreads were analyzed for each genotype. Centromeric cohesion was scored as "normal" when fewer than three chromosomes showed gaps between sister chromatid centromeres, or "defective" when more than two chromosomes showed gaps. Arm cohesion was scored as "normal" when fewer than three chromosomes showed fully separated chromosome arms, or "defective" when more than two chromosomes showed fully separated chromosome arms. For chromosome counts, 100 cells were analyzed for each cell type, with and without treatment with 0.04 μg/ml MMC for 40 hr prior to metaphase arrest. The same conditions were used for analysis of structural chromosome aberrations, with 2,033 and 2,133 chromosomes analyzed for +/+ and −/− mESCs, respectively.

FISH {#sec4.3}
----

1BR-hTERT cells transfected with siControl or siBAF180 were treated with 0.1 μg/ml colcemid for 3 hr to arrest in metaphase before mitotic cells were dislodged. Cells were washed with PBS and fixed in Carnoy's fixative. FISH was performed essentially as described previously ([@bib7]). Cells were hybridized overnight with either DNA probes against arm and centromere regions of chromosome 10 (DiGeorge II probe, LPU015; Cytocell) or subtelomeric regions of chromosome 16 (chromosome 16ptel05 probe, LPT16R; Cytocell) according to the manufacturer's protocol. Nuclei were stained with ProLong Gold Antifade Reagent with DAPI.

Transcript Analysis {#sec4.4}
-------------------

RNA was extracted from the indicated cell lines using an RNeasy kit (QIAGEN). Then 1 μg of RNA was reverse transcribed into cDNA for analysis by qPCR using primers specific to the indicated locus (using QuantiTect Primer Mix from QIAGEN).

IF-FISH {#sec4.5}
-------

For IF-FISH, 4 × 10^5^ U20S cells were plated onto glass coverslips and transfected with 20 nM BAF180 single siRNA (Invitrogen) or nontargeting control siRNA using HiPerFect transfection reagent (QIAGEN). After 19 hr, cells were treated with 2.5 mM thymidine for 17 hr before being released. At 9 hr after release, cells were transfected with the siRNA-resistant plasmids pEGFP, pEGFP-BAF180r, pEGFP-BAF180r-T232P, and pEGFP-BAF180r-M538I using NanoJuice Core transfection reagent (Merck Chemicals). After 5 hr, the cells were washed with PBS and subjected to a second thymidine block using 2.5 mM thymidine for a further 17 hr. At 8 hr after release, the cells were fixed with 3% paraformaldehyde (PFA).

For IF, cells were blocked in blocking solution (3% BSA, 0.1% Triton X-100, 1 mM EDTA pH 8.0 in PBS) for 30 min at room temperature, and subjected to antibody incubation in blocking solution. Immunostained cells were fixed in 3% PFA for 10 min at room temperature. DNA FISH was performed according to [@bib10]). Nuclei were stained with ProLong Gold Antifade Reagent with DAPI.

Yeast Survival and Recombination Assays {#sec4.6}
---------------------------------------

Cultures of Δ*rsc2* DMY3010 strain transformed with pRsc2-myc, pRsc2-T67P-myc, pRsc2-M280I-myc, pRsc2-H458P-myc, or pRsc2-D540G-myc plasmids were grown to mid-log phase in synthetic complete media lacking tryptophan. Serial dilutions were spotted or plated onto plates containing the indicated drug. Colonies for survival assays were counted 3 days after plating. Recombination assays were performed as described previously ([@bib15]). Ten- to twenty-thousand colonies were analyzed per strain.

Analysis of Micronuclei and Aberrant Mitoses {#sec4.7}
--------------------------------------------

For mESCs, spontaneous micronuclei were counted in interphase cells from two independent experiments (total counts: 983 +/+ cells, 1,043 −/− cells). For 1BR-hTERT cells, three separate knockdown experiments were analyzed (total counts: 2,629 for siControl, 2,716 for siBAF180). In experiments to analyze the effect of MMC on micronuclei formation, 563 +/+ and 676 −/− cells were counted. DNA staining was performed using ProLong Gold Antifade Reagent with DAPI. Analysis of aberrant mitoses was performed on 183 +/+ and 207 −/− anaphase mESCs from two independent experiments.

Viability Assays {#sec4.8}
----------------

Viability assays following treatment with MMC were performed in 96-well format in triplicate at the stated doses; 1 × 10^4^ mESCs and 5 × 10^3^ 1BR-hTERT cells were plated per well. Viability was analyzed 4 days following treatment using CellTiter-Glo Reagent (Promega).

Statistical Analyses {#sec4.9}
--------------------

Frequency counts for cohesion scoring, spontaneous micronuclei, abnormal anaphases, and structural chromosome aberration assays were analyzed with a two-tailed Fisher's exact test using GraphPad software. Distribution counts from FISH experiments were analyzed using the Kolmogorov-Smirnov test. Differences in recombination frequency and survival assays were analyzed with an unpaired two-tailed t test using GraphPad software. Significance was indicated as ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures and Figures S1--S5Document S2. Article plus Supplemental Information
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![BAF180 Promotes Centromeric Sister Chromatid Cohesion\
(A and B) Mitotic spreads prepared from WT (+/+) and BAF180 knockout (−/−) mESCs were analyzed for sister chromatid cohesion at either centromeres (A) or arms (B). Representative images from WT and BAF180^−/−^ mESCs are shown in the top panels. Cells were analyzed according to whether cohesion was defective at centromeres (open arrows) or arms (open and closed arrows), and cells were scored as "normal" when two or fewer chromosomes showed defects, or "defective" when three or more chromosomes showed defects; 200 cells were scored per genotype.\
(C) Analysis of BAF180 depletion efficiency in 1BR-hTERT cells by western blotting. Anti-tubulin was used as a loading control.\
(D) FISH analysis of siControl and siBAF180 1BR-hTERT cells using probes directed against the centromere (top, p \< 0.001), telomere (middle, p = 0.877), or chromosome arm (lower panel, p = 0.586). The distances between signals were measured from two independent experiments and the distribution was plotted as a histogram.\
(E) Analysis of BAF180 protein levels in U2OS shBAF180 and shControl stable cells by western blotting. Anti-tubulin was used as a loading control.\
(F) FISH analysis of shControl and shBAF180 U20S cells using a probe directed against the centromere (p \< 0.001). The distances between signals were measured from two independent experiments and the distribution was plotted as a histogram.\
See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![BAF180 Is Not Required for Transcription of Cohesin Genes and Has Tissue-Specific Roles in Regulating p53-Dependent p21 Transcription\
(A) Western blot analysis of cohesin subunits in WCE prepared from WT (+/+) and BAF180 knockout (−/−) mESCs.\
(B) Transcription of cohesin subunits in BAF180-depleted 1BR-hTert cells. Transcript levels from three independent experiments were analyzed by qPCR and normalized to α-tubulin transcript. Data for BAF180-depleted cells are shown relative to siControl cells.\
(C) Transcription of cohesin subunits in shBAF180 U2OS cells. Transcript levels from three independent experiments were analyzed by qPCR and normalized to α-tubulin. Data for shBAF180 cells are shown relative to shControl cells.\
(D) Transcription of p21 in BAF180-depleted 1BR-hTert and U2OS cells. Transcript levels from three independent experiments were analyzed by qPCR and normalized to β-actin. Data for BAF180-depleted cells are shown relative to control cells.\
See also [Figure S2](#app2){ref-type="sec"}.](gr2){#fig2}

![Mutations Identified in BAF180 from Cancer Samples Result in Impaired Cohesin-Dependent Functions in Yeast and Mammals\
(A) Illustration of domain organization and relative position of cancer-associated mutations in Rsc2 and BAF180. BDs and BAH domains are numbered sequentially.\
(B) Analysis of WT and mutant Rsc2 expression levels in total protein preparations by western blotting. Loading control: anti-H2A.\
(C) Hypersensitivity to DMSO as a readout of Rsc2-dependent transcriptional activity was analyzed by plating serial dilutions of the indicated mid-log cultures onto media with or without 2% DMSO.\
(D) Frequency of unequal rDNA crossover events in yeast strains containing the indicated Rsc2 expression construct.\
(E) Expression of GFP-tagged BAF180 constructs in siBAF180 U20S. Cells were treated as in (G) and [Figure S4](#app2){ref-type="sec"}, for IF-FISH. IF using anti-GFP shows GFP or GFP-BAF180 expression in the red channel.\
(F) Analysis of BAF180 depletion efficiency in U2OS cells by western blotting. Anti-tubulin was used as a loading control.\
(G) FISH analysis of G2 phase U2OS cells transfected with the indicated BAF180 expression construct using a probe against centromere 10. The distances between signals were measured and the distribution was plotted as a histogram.\
(H) The data in (G) are presented as a cumulative plot to further illustrate the defect in cohesion in cells transfected with cancer-associated mutants. Statistical analysis of the data presented in (G) and (H) showed that rescue of the cohesion defect by reintroduction of WT BAF180 (siBAF180 + GFP-BAF180) was significant (p \< 0.001). In contrast, centromeric cohesion in cells expressing the cancer mutants was not significantly different from that in BAF180-depleted cells containing empty vector (siBAF180 + GFP; p = 0.06 for T232P and p = 0.37 for M538I), but was significantly different from that in cells with WT BAF180 reintroduced (p \< 0.001 for both mutants compared with WT).\
See also [Figures S3](#app2){ref-type="sec"} and [S4](#app2){ref-type="sec"}.](gr3){#fig3}

![Cells Lacking BAF180 Are Aneuploid and Show Evidence of CIN\
(A) Distribution curves showing chromosome numbers from WT (+/+) and BAF180 knockout (−/−) mESCs. Chromosomes were counted in 100 cells for each cell line using DAPI-stained metaphase spreads.\
(B) Quantification of micronuclei present in WT (+/+) or BAF180 knockout (−/−) mESCs (top panel), control and BAF180-depleted 1BR-hTERT cells (middle panel), and shControl and shBAF180 U2OS cells (bottom panel). A minimum of 900 cells were scored for each cell line, and siRNA-depleted cells from three independent experiments were analyzed.\
(C) Incidence of abnormal events during anaphase were quantified in WT (+/+; n = 183) and BAF180 knockout (−/−; n = 207) mESCs.](gr4){#fig4}

![Loss of BAF180 Leads to Hypersensitivity to DNA Damage, Increased Frequency of Chromosome Aberrations, and Dynamic CIN\
(A) Viability curves of WT (+/+) or BAF180 knockout (−/−) mESCs (left panel), and control and BAF180-depleted 1BR-hTERT cells (right panel) following exposure to MMC.\
(B) The presence of chromosomal aberrations in metaphase spreads prepared from WT (+/+) or BAF180 knockout (−/−) mESCs following exposure to MMC was analyzed and presented as frequency per 100 chromosomes. Images representative of each category are shown in the top panels.\
(C) Quantification of micronuclei present in WT (+/+) or BAF180 knockout (−/−) mESCs following exposure to MMC.\
(D) Distribution curves showing chromosome numbers from WT (+/+) and BAF180 knockout (−/−) mESCs following exposure to MMC.\
See also [Figure S5](#app2){ref-type="sec"}.](gr5){#fig5}

###### 

Average Number and Range per Cell of Chromosomal Aberrations in mESCs following MMC Exposure

  Category            +/+          −/−
  ------------------- ------------ -------------
  Chromatid breaks    0.5 (0--3)   2.2 (0--14)
  Chromosome breaks   0.3 (0--4)   0.8 (0--10)
  Triradial           0.1 (0--2)   0.1 (0--1)
  Quadriradial        0 (0--0)     0.02 (0--1)
  Fusion              0.3 (0--2)   0.5 (0--8)
  Total               2.2 (0--6)   4.6 (0--32)
